MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

European physiotherapy guideline for Parkinson’s disease: Information for neurologists

D.L.M. Radder, M.J. Faber, N.M. de Vries, B.R. Bloem, S.H.J. Keus (Nijmegen, Netherlands)

Meeting: 2016 International Congress

Abstract Number: 1786

Keywords: Gait disorders: Treatment, Multidisciplinary Approach

Session Information

Date: Thursday, June 23, 2016

Session Title: Other

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: We aim to inform physicians on the value of physiotherapy (PT) for people with Parkinson’s disease (PwP) and on opportunities to optimize referral to and communication with PTs. Recommendations are based on the part of the European Physiotherapy Guideline for Parkinson’s disease (PD) for physicians.

Background: PD is a complex condition, requiring involvement of health professionals from various disciplines. The evidence-base for high quality, non-pharmacological care for PwP is growing and its implementation is gaining momentum. The Guideline supports PTs in making patient-centered, evidence-based decisions. Specific information for physicians and for PwP is included, to improve the implementation of good PT care.

Methods: The Guideline was developed in a joint collaboration of national PT associations from 19 European countries. Opinion leaders, PT’s, physicians and patients were informed and involved in the developmental process. The Guideline was based on a systematic analysis of the literature, according to international standards (AGREE and GRADE).

Results: Referral to PT should be considered in the early stage of disease, at the onset of activity limitations and at hospital admission. Early referral is desired, because difficulties in daily activities may already be present. PTs can support PwP in self-management by education about maintaining sufficient physical activity levels. Also in later stages there is consistent evidence supporting PT referral, e.g. to improve gait and prevent falls. At hospital admission PTs can provide education and exercise for prevention of pressure sores and a decrease of physical capacity. During and upon completion of a treatment period, the PT will communicate with the referring neurologist about the treatment goal (determined together with the patient), treatment plan and (expected) effect, supported by validated assessment tools. The referring physician has an important role in guiding PwP to an expert PT, as nearly all PwP will follow their physician’s advice. Expert PT’s are fully-informed regarding the evidence on PT-specific interventions and treat a higher than average patient volume, which is essential for good PD care.

Conclusions: PwP can benefit from PT treatment in all disease stages and referral to PT should be considered even in the early stages. The Guideline, including the physicians and PwP parts, is openly available at www.parkinsonnet.info/euguideline.

To cite this abstract in AMA style:

D.L.M. Radder, M.J. Faber, N.M. de Vries, B.R. Bloem, S.H.J. Keus. European physiotherapy guideline for Parkinson’s disease: Information for neurologists [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/european-physiotherapy-guideline-for-parkinsons-disease-information-for-neurologists/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/european-physiotherapy-guideline-for-parkinsons-disease-information-for-neurologists/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley